Clinical data indicate that HPAH patients with these mutations have a more severe form of HPAH with reduced time until lung transplant and an earlier age of diagnosis[20], suggesting that these mutant protein products are expressed and may have dominant negative effects on BMPR2 function. This evidence concerns the gene BMPR2 and heritable pulmonary arterial hypertension.